Kontigo Care AB (publ) (KONT.ST)
SEK 2.64
(-1.49%)
SEK 2.64
(-1.49%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 52 Thousand SEK | -98.21% |
| 2022 | 2.9 Million SEK | 362.21% |
| 2021 | -1.1 Million SEK | -0.21% |
| 2020 | -1.1 Million SEK | 7.46% |
| 2019 | -1.19 Million SEK | 81.88% |
| 2018 | -6.58 Million SEK | 53.07% |
| 2017 | -14.02 Million SEK | 27.05% |
| 2016 | -19.21 Million SEK | -34.98% |
| 2015 | -14.23 Million SEK | -1095.63% |
| 2014 | -1.19 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 201 Thousand SEK | 138.73% |
| 2024 Q2 | 516 Thousand SEK | 156.72% |
| 2023 Q3 | 1.58 Million SEK | 524.87% |
| 2023 Q4 | -519 Thousand SEK | -132.66% |
| 2023 FY | 52 Thousand SEK | -98.21% |
| 2023 Q1 | -438 Thousand SEK | -378.98% |
| 2023 Q2 | -374 Thousand SEK | 14.61% |
| 2022 Q3 | 1.37 Million SEK | 14.86% |
| 2022 FY | 2.9 Million SEK | 362.21% |
| 2022 Q2 | 1.19 Million SEK | 608.88% |
| 2022 Q1 | 169 Thousand SEK | 138.15% |
| 2022 Q4 | 157 Thousand SEK | -88.59% |
| 2021 Q3 | 355 Thousand SEK | 156.08% |
| 2021 FY | -1.1 Million SEK | -0.21% |
| 2021 Q1 | -385 Thousand SEK | -662.48% |
| 2021 Q2 | -633 Thousand SEK | -64.42% |
| 2021 Q4 | -443 Thousand SEK | -224.79% |
| 2020 Q4 | -50.49 Thousand SEK | -125.63% |
| 2020 Q3 | 197 Thousand SEK | 134.74% |
| 2020 FY | -1.1 Million SEK | 7.46% |
| 2020 Q2 | -567 Thousand SEK | 17.83% |
| 2020 Q1 | -690 Thousand SEK | -695.97% |
| 2019 FY | -1.19 Million SEK | 81.88% |
| 2019 Q3 | 29 Thousand SEK | 104.54% |
| 2019 Q4 | 115.77 Thousand SEK | 299.23% |
| 2019 Q2 | -639 Thousand SEK | 17.97% |
| 2019 Q1 | -779 Thousand SEK | 47.93% |
| 2018 Q4 | -1.49 Million SEK | -66.6% |
| 2018 Q3 | -898 Thousand SEK | 55.14% |
| 2018 Q1 | -2.18 Million SEK | 35.74% |
| 2018 Q2 | -2 Million SEK | 8.42% |
| 2018 FY | -6.58 Million SEK | 53.07% |
| 2017 Q2 | -4.4 Million SEK | -8.55% |
| 2017 FY | -14.02 Million SEK | 27.05% |
| 2017 Q4 | -3.4 Million SEK | -57.86% |
| 2017 Q1 | -4.05 Million SEK | 11.24% |
| 2017 Q3 | -2.15 Million SEK | 51.09% |
| 2016 Q1 | -4.93 Million SEK | -126.79% |
| 2016 Q4 | -4.57 Million SEK | -22.67% |
| 2016 Q2 | -5.98 Million SEK | -21.35% |
| 2016 FY | -19.21 Million SEK | -34.98% |
| 2016 Q3 | -3.72 Million SEK | 37.72% |
| 2015 FY | -14.23 Million SEK | -1095.63% |
| 2015 Q4 | -2.17 Million SEK | 30.59% |
| 2015 Q1 | -3.79 Million SEK | -1289.0% |
| 2015 Q2 | -5.14 Million SEK | -35.58% |
| 2015 Q3 | -3.13 Million SEK | 39.03% |
| 2014 Q4 | -272.93 Thousand SEK | 44.86% |
| 2014 Q1 | -211.5 Thousand SEK | 0.0% |
| 2014 FY | -1.19 Million SEK | 0.0% |
| 2014 Q3 | -495 Thousand SEK | -25.95% |
| 2014 Q2 | -393 Thousand SEK | -85.82% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aino Health AB (publ) | -9.51 Million SEK | 100.547% |
| Bonzun AB (publ) | -25.25 Million SEK | 100.206% |
| Medhelp Care Aktiebolag (publ) | -10.48 Million SEK | 100.496% |
| RaySearch Laboratories AB (publ) | 114.88 Million SEK | 99.955% |
| Surgical Science Sweden AB (publ) | 191.28 Million SEK | 99.973% |